379 related articles for article (PubMed ID: 9257925)
1. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine, losartan and captopril effects on hyperplasia of vascular smooth muscle from Ren-2 transgenic rats.
Peiró C; Angulo J; Regadera J; Llergo JL; Sánchez-Ferrer A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Eur J Pharmacol; 1997 Apr; 324(2-3):257-65. PubMed ID: 9145781
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II mediates cell hypertrophy in vascular smooth muscle cultures from hypertensive Ren-2 transgenic rats by an amiloride- and furosemide-sensitive mechanism.
Peiró C; Angulo J; Llergo JL; Rodríguez-Mañas L; Marín J; Sánchez-Ferrer CF
Biochem Biophys Res Commun; 1997 Nov; 240(2):367-71. PubMed ID: 9388483
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
6. Endogenous angiotensin II and cell hypertrophy in vascular smooth muscle cultures from hypertensive Ren-2 transgenic rats.
Peiró C; Rodríguez-López AM; Angulo J; Regadera J; Marín J; Sánchez-Ferrer CF; López-Novoa JM
Cell Physiol Biochem; 1998; 8(1-2):106-16. PubMed ID: 9547018
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
O'Sullivan JB; Black MJ; Bertram JF; Bobik A
J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
[TBL] [Abstract][Full Text] [Related]
8. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II.
Devlin AM; Davidson AO; Gordon JF; Campbell AM; Morton JJ; Reid JL; Dominiczak AF
J Hum Hypertens; 1995 Jun; 9(6):497-500. PubMed ID: 7473534
[TBL] [Abstract][Full Text] [Related]
11. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size.
Berk BC; Rao GN
J Cell Physiol; 1993 Feb; 154(2):368-80. PubMed ID: 8425918
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
[TBL] [Abstract][Full Text] [Related]
14. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Iouzalen L; Stepien O; Marche P
J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
[TBL] [Abstract][Full Text] [Related]
15. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
Soltis EE
J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.
Smits JF; van Krimpen C; Schoemaker RG; Cleutjens JP; Daemen MJ
J Cardiovasc Pharmacol; 1992; 20(5):772-8. PubMed ID: 1280740
[TBL] [Abstract][Full Text] [Related]
18. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells.
Ling H; Vamvakas S; Schaefer L; Schnittler HJ; Schaefer RM; Heidland A
Nephrol Dial Transplant; 1995; 10(8):1305-12. PubMed ID: 8538919
[TBL] [Abstract][Full Text] [Related]
20. Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
Ling Q; Guo ZG; Su Z; Guo X
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):206-10. PubMed ID: 7976371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
